Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:VRAY

ViewRay (VRAY) Stock Price, News & Analysis

ViewRay logo

About ViewRay Stock (NASDAQ:VRAY)

Key Stats

Today's Range
N/A
50-Day Range
$0.03
$0.65
52-Week Range
N/A
Volume
108.50 million shs
Average Volume
7.51 million shs
Market Capitalization
$4.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado.

Receive VRAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ViewRay and its competitors with MarketBeat's FREE daily newsletter.

VRAY Stock News Headlines

ViewRay Inc (VRAYQ) Earnings Dates & Reports
VRAY Jan 2025 2.000 call
9 hidden AI stocks set to thrive in Trump’s new era
AI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)
VRAY Jan 2025 0.500 put
VRAY Jan 2025 0.500 call
VRAY Jan 2025 3.000 put
ViewRay Inc VRAYQ
NUBURU Appoints Brian Knaley as new CEO
See More Headlines

VRAY Stock Analysis - Frequently Asked Questions

ViewRay, Inc. (NASDAQ:VRAY) issued its quarterly earnings results on Monday, February, 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.16) by $0.01. The company's revenue was up 70.1% compared to the same quarter last year.

ViewRay subsidiaries include Vesuvius Acquisition Corp., ViewRay GmbH, and ViewRay Technologies Inc..

ViewRay (VRAY) raised $52 million in an initial public offering (IPO) on the week of April 6th 2015. The company issued 4,000,000 shares at $12.00-$14.00 per share. Cowen and Company and Stifel acted as the underwriters for the IPO and BTIG and Brean Capital were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that ViewRay investors own include Alibaba Group (BABA), Meta Platforms (META), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), NVIDIA (NVDA), Bristol-Myers Squibb (BMY) and Amarin (AMRN).

Company Calendar

Last Earnings
2/27/2023
Today
11/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:VRAY
Employees
295
Year Founded
2004

Profitability

Net Income
$-107,330,000.00
Net Margins
-104.30%
Pretax Margin
-104.30%

Debt

Sales & Book Value

Annual Sales
$105.86 million
Book Value
$0.45 per share

Miscellaneous

Free Float
178,817,000
Market Cap
$4.59 million
Optionable
Optionable
Beta
0.81

Social Links

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:VRAY) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners